Page last updated: 2024-09-05

deferasirox and Chronic Illness

deferasirox has been researched along with Chronic Illness in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kontoghiorghes, GJ	1
Bagust, A; Boland, A; Chu, P; Dickson, R; Dundar, Y; Fleeman, N; Greenhalgh, J; Kirkham, J; McLeod, C; Modell, B; Olujohungbe, A; Telfer, P; Walley, T	1
Fujita, T; Haba, R; Nishiuchi, T; Ohnishi, H; Okutani, Y; Yoshida, K	1
Bertrand, DM; Eas, F; Godin, M; Grangé, S; Guerrot, D	1
Keam, SJ; Keating, GM; Yang, LP	1

Reviews

2 review(s) available for deferasirox and Chronic Illness

Article	Year
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 2009, Volume: 13, Issue:1 Topics: Anemia; Benzoates; Chronic Disease; Contraindications; Cost-Benefit Analysis; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemosiderosis; Humans; Iron Chelating Agents; Pyridones; Randomized Controlled Trials as Topic; Technology Assessment, Biomedical; Transfusion Reaction; Treatment Outcome; Triazoles	2009
Deferasirox : a review of its use in the management of transfusional chronic iron overload. Drugs, 2007, Volume: 67, Issue:15 Topics: Animals; Benzoates; Blood Transfusion; Chronic Disease; Deferasirox; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Transfusion Reaction; Triazoles	2007

Article

Year

Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.

Health technology assessment (Winchester, England), 2009, Volume: 13, Issue:1

Topics: Anemia; Benzoates; Chronic Disease; Contraindications; Cost-Benefit Analysis; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemosiderosis; Humans; Iron Chelating Agents; Pyridones; Randomized Controlled Trials as Topic; Technology Assessment, Biomedical; Transfusion Reaction; Treatment Outcome; Triazoles

2009

Deferasirox : a review of its use in the management of transfusional chronic iron overload.

Drugs, 2007, Volume: 67, Issue:15

Topics: Animals; Benzoates; Blood Transfusion; Chronic Disease; Deferasirox; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Transfusion Reaction; Triazoles

2007

Other Studies

3 other study(ies) available for deferasirox and Chronic Illness

Article	Year
Turning a blind eye to deferasirox's toxicity? Lancet (London, England), 2013, Apr-06, Volume: 381, Issue:9873 Topics: Age Factors; Benzoates; Cause of Death; Chronic Disease; Deferasirox; Drug Approval; Europe; Hematologic Diseases; Humans; Iron Chelating Agents; Iron Overload; Triazoles	2013
Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome. International journal of hematology, 2010, Volume: 91, Issue:2 Topics: Aged; Anemia; Benzoates; Chronic Disease; Deferasirox; Female; Humans; Iron Chelating Agents; Iron Overload; Myelodysplastic Syndromes; Radiography; Thrombocytopenia; Transfusion Reaction; Triazoles	2010
Acute renal failure and Fanconi syndrome due to deferasirox. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:7 Topics: Acute Kidney Injury; Aged; Benzoates; Chronic Disease; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Iron Overload; Kidney; Male; Triazoles	2010